Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xavier Monzonis"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Emergence of acquired resistance limits the efficacy of the anti-EGFR therapies cetuximab and panitumumab in metastatic colorectal cancer. In the last decade, preclinical and clinical cohort studies have uncovered genomic alterations that confer a se
Externí odkaz:
https://doaj.org/article/c28e85a75e614631a6dc3789a815a36c
Autor:
Xavier Monzonis, Daniel Echeverría-Esnal, Inés Monge-Escartín, Edurne Arriola, L. Moliner, Álvaro Taus, Xavier Duran-Jordà, Alejandro Ríos-Hoyo, David Conde-Estévez
Publikováno v:
Journal of Chemotherapy. 33:32-39
Our aim was to describe the incidence and characteristics of immune-related adverse events (irAEs) in patients with non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI) and to evaluate their impact on outcome. All cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8554e6fc692b1e809e31eea6188143e
https://doi.org/10.1080/1120009x.2020.1849488
https://doi.org/10.1080/1120009x.2020.1849488
Abstract 423: Pooled analysis of matching score and patient outcome in I-PREDICT and WINTHER studies
Publikováno v:
Cancer Research. 81:423-423
Introduction: Comprehensive genomic profiling (CGP) of tumors is available at many specialized cancer centers, potentially allowing oncologists to individualize patient therapy based on tumor molecular features. However, clinicians still lack a syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e84c92f9ad25ea66b0dfe1506a3909c
https://doi.org/10.1158/1538-7445.am2021-423
https://doi.org/10.1158/1538-7445.am2021-423
Autor:
Edurne Arriola, Xavier Monzonis
Publikováno v:
Journal of Thoracic Oncology. 14:e247-e248
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9527c844b0b5d59294b66b302a2b337f
https://doi.org/10.1016/j.jtho.2019.06.013
https://doi.org/10.1016/j.jtho.2019.06.013